Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis

1.

Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zagórowicz E, Raine T, Harbord M, Rieder F (2017) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and Ileo-anal Pouch disorders. J Crohn's Colitis 11(6):649–670. https://doi.org/10.1093/ecco-jcc/jjx008 CrossRef

2.

Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, Laureti S, Sampietro GM, Vucelic B, van der Woude CJ, Barreiro-de Acosta M, Maaser C, Portela F, Vavricka SR, Gomollón F, ECCO (2017) 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical management and special situations. J Crohn's Colitis 11(2):135–149. https://doi.org/10.1093/ecco-jcc/jjw169 CrossRef

3.

Brown SR, Fearnhead NS, Faiz OD, Abercrombie JF, Acheson AG, Arnott RG, Clark SK, Clifford S, Davies RJ, Davies MM, Douie WJP, Dunlop MG, Epstein JC, Evans MD, George BD, Guy RJ, Hargest R, Hawthorne AB, Hill J, Hughes GW, Limdi JK, Maxwell-Armstrong CA, O'Connell PR, Pinkney TD, Pipe J, Sagar PM, Singh B, Soop M, Terry H, Torkington J, Verjee A, Walsh CJ, Warusavitarne JH, Williams AB, Williams GL, Wilson RG, Collaboration AISC (2018) The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis 20(Suppl 8):3–117. https://doi.org/10.1111/codi.14448 CrossRefPubMed

4.

Ross H, Steele SR, Varma M, Dykes S, Cima R, Buie WD, Rafferty J, Surgeons SPTFotASoCaR (2014) Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum 57(1):5–22. https://doi.org/10.1097/DCR.0000000000000030 CrossRefPubMed

5.

Øresland T, Bemelman WA, Sampietro GM, Spinelli A, Windsor A, Ferrante M, Marteau P, Zmora O, Kotze PG, Espin-Basany E, Tiret E, Sica G, Panis Y, Faerden AE, Biancone L, Angriman I, Serclova Z, van Overstraeten AB, Gionchetti P, Stassen L, Warusavitarne J, Adamina M, Dignass A, Eliakim R, Magro F, D’Hoore A (2015) European evidence based consensus on surgery for ulcerative colitis. J Crohn's Colitis 9(1):4–25. https://doi.org/10.1016/j.crohns.2014.08.012 CrossRef

6.

Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, Adamina M, Armuzzi A, Bachmann O, Bager P, Biancone L, Bokemeyer B, Bossuyt P, Burisch J, Collins P, El-Hussuna A, Ellul P, Frei-Lanter C, Furfaro F, Gingert C, Gionchetti P, Gomollon F, González-Lorenzo M, Gordon H, Hlavaty T, Juillerat P, Katsanos K, Kopylov U, Krustins E, Lytras T, Maaser C, Magro F, Marshall JK, Myrelid P, Pellino G, Rosa I, Sabino J, Savarino E, Spinelli A, Stassen L, Uzzan M, Vavricka S, Verstockt B, Warusavitarne J, Zmora O, Fiorino G (2019) ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment. J Crohn's Colitis. https://doi.org/10.1093/ecco-jcc/jjz180 CrossRef

7.

Pellino G, Selvaggi F, Ghezzi G, Corona D, Riegler G, Delaini GG (2015) A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease. Tech Coloproctol 19(10):639–651. https://doi.org/10.1007/s10151-015-1368-4 CrossRefPubMed

8.

Selvaggi F, Pellino G, Ghezzi G, Corona D, Riegler G, Delaini GG (2015) A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis. Tech Coloproctol 19(10):627–638. https://doi.org/10.1007/s10151-015-1367-5 CrossRefPubMed

9.

Pellino G, Keller DS, Sampietro GM, Angriman I, Carvello M, Celentano V, Colombo F, Di Candido F, Laureti S, Luglio G, Poggioli G, Rottoli M, Scaringi S, Sciaudone G, Sica G, Sofo L, Leone S, Danese S, Spinelli A, Delaini G, Selvaggi F, on behalf of the Italian Society of Colorectal Surgery SICCR (2020) Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn’s disease. Tech Coloproctol. https://doi.org/10.1007/s10151-020-02183-z CrossRefPubMed

10.

Turner D, Walsh CM, Steinhart AH, Griffiths AM (2007) Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 5(1):103–110. https://doi.org/10.1016/j.cgh.2006.09.033 CrossRefPubMed

11.

Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330(26):1841–1845. https://doi.org/10.1056/NEJM199406303302601 CrossRefPubMed

12.

Van Assche G, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, Arts J, D'Hoore A, Penninckx F, Rutgeerts P (2003) Randomized, double-blind comparison of 4 mg/kg vs 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125(4):1025–1031. https://doi.org/10.1016/s0016-5085(03)01214-9 CrossRefPubMed

13.

Cheifetz AS, Stern J, Garud S, Goldstein E, Malter L, Moss AC, Present DH (2011) Cyclosporine is safe and effective in patients with severe ulcerative colitis. J Clin Gastroenterol 45(2):107–112. https://doi.org/10.1097/MCG.0b013e3181e883dd CrossRefPubMed

14.

Bamba S, Tsujikawa T, Inatomi O, Nakahara T, Koizumi Y, Saitoh Y, Sasaki M, Fujiyama Y, Andoh A (2010) Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis. J Gastroenterol Hepatol 25(3):494–498. https://doi.org/10.1111/j.1440-1746.2009.06119.x CrossRefPubMed

15.

Sternthal MB, Murphy SJ, George J, Kornbluth A, Lichtiger S, Present DH (2008) Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 103(4):937–943. https://doi.org/10.1111/j.1572-0241.2007.01718.x CrossRefPubMed

16.

Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128(7):1805–1811. https://doi.org/10.1053/j.gastro.2005.03.003 CrossRefPubMed

17.

Gustavsson A, Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Verbaan H, Hellström PM, Magnuson A, Halfvarson J, Tysk C (2010) Clinical trial: colectomy after rescue therapy in ulcerative colitis—3-year follow-up of the Swedish–Danish controlled infliximab study. Aliment Pharmacol Ther 32(8):984–989. https://doi.org/10.1111/j.1365-2036.2010.04435.x CrossRefPubMed

18.

Sjöberg M, Magnuson A, Björk J, Benoni C, Almer S, Friis-Liby I, Hertervig E, Olsson M, Karlén P, Eriksson A, Midhagen G, Carlson M, Lapidus A, Halfvarson J, Tysk C, (SOIBD) SOftSoIBD (2013) Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients. Aliment Pharmacol Ther 38(4):377–387. https://doi.org/10.1111/apt.12387 CrossRefPubMed

19.

Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK, Rutgeerts P (2007) Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis 13(2):123–128. https://doi.org/10.1002/ibd.20054 CrossRefPubMed

20.

Mortensen C, Caspersen S, Christensen NL, Svenningsen L, Thorsgaard N, Christensen LA, Bendtsen F (2011) Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals. J Crohn's Colitis 5(1):28–33. https://doi.org/10.1016/j.crohns.2010.09.004 CrossRef

21.

Halpin SJ, Hamlin PJ, Greer DP, Warren L, Ford AC (2013) Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience. World J Gastroenterol WJG 19(7):1091–1097. https://doi.org/10.3748/wjg.v19.i7.1091 CrossRefPubMed

22.

Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P (2014) Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy. Internal Med J 44(5):464–470. https://doi.org/10.1111/imj.12397 CrossRef

23.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M, Digestives GdETdAI (2012) Ciclosporin vs infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 380(9857):1909–1915. https://doi.org/10.1016/S0140-6736(12)61084-8 CrossRefPubMed

24.

Croft A, Walsh A, Doecke J, Cooley R, Howlett M, Radford-Smith G (2013) Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs infliximab. Aliment Pharmacol Ther 38(3):294–302. https://doi.org/10.1111/apt.12375 CrossRefPubMed

25.

Seow CH, Newman A, Irwin SP, Steinhart AH, Silverberg MS, Greenberg GR (2010) Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut 59(1):49–54. https://doi.org/10.1136/gut.2009.183095 CrossRefPubMed

26.

Kevans D, Murthy S, Mould DR, Silverberg MS (2018) Accelerated clearance of infliximab is associated with treatment failure in patients with corticosteroid-refractory acute ulcerative colitis. J Crohn's Colitis 12(6):662–669. https://doi.org/10.1093/ecco-jcc/jjy028 CrossRef

27.

Brandse JF, van den Brink GR, Wildenberg ME, van der Kleij D, Rispens T, Jansen JM, Mathôt RA, Ponsioen CY, Löwenberg M, D'Haens GR (2015) Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis. Gastroenterology 149(2):350–355.e352. https://doi.org/10.1053/j.gastro.2015.04.016 CrossRefPubMed

28.

Gibson DJ, Heetun ZS, Redmond CE, Nanda KS, Keegan D, Byrne K, Mulcahy HE, Cullen G, Doherty GA (2015) An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. Clin Gastroenterol Hepatol 13(2):330–335.e331. https://doi.org/10.1016/j.cgh.2014.07.041 CrossRefPubMed

29.

Govani SM, Stidham RW, Higgins PD (2013) How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal strictures. J Crohn's Colitis 7(11):923–927. https://doi.org/10.1016/j.crohns.2013.06.011 CrossRef

30.

Shah SC, Naymagon S, Panchal HJ, Sands BE, Cohen BL, Dubinsky MC (2018) Accelerated infliximab dosing increases 30-day colectomy in hospitalized ulcerative colitis patients: a propensity score analysis. Inflamm Bowel Dis 24(3):651–659. https://doi.org/10.1093/ibd/izx039 CrossRefPubMed

31.

Choy MC, Seah D, Gorelik A, An YK, Chen CY, Macrae FA, Sparrow MP, Connell WR, Moore GT, Radford-Smith G, Van Langenberg DR, De Cruz P (2018) Predicting response after infliximab salvage in acute severe ulcerative colitis. J Gastroenterol Hepatol 33(7):1347–1352. https://doi.org/10.1111/jgh.14072 CrossRefPubMed

32.

Hindryckx P, Novak G, Vande Casteele N, Laukens D, Parker C, Shackelton LM, Narula N, Khanna R, Dulai P, Levesque BG, Sandborn WJ, D'Haens G, Feagan BG, Jairath V (2017) Review article: dose optimisation of infliximab for acute severe ulcerative colitis. Aliment Pharmacol Ther 45(5):617–630. https://doi.org/10.1111/apt.13913 CrossRefPubMedPubMedCentral

33.

Choy MC, Seah D, Faleck DM, Shah SC, Chao CY, An YK, Radford-Smith G, Bessissow T, Dubinsky MC, Ford AC, Churilov L, Yeomans ND, De Cruz PP (2019) Systematic review and meta-analysis: optimal salvage therapy in acute severe ulcerative colitis. Inflamm Bowel Dis 25(7):1169–1186. https://doi.org/10.1093/ibd/izy383 CrossRefPubMedPubMedCentral

34.

Ogata H, Matsui T, Nakamura M, Iida M, Takazoe M, Suzuki Y, Hibi T (2006) A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 55(9):1255–1262. https://doi.org/10.1136/gut.2005.081794 CrossRefPubMedPubMedCentral

35.

Komaki Y, Komaki F, Ido A, Sakuraba A (2016) Efficacy and safety of tacrolimus therapy for active ulcerative colitis; a systematic review and meta-analysis. J Crohn's Colitis 10(4):484–494. https://doi.org/10.1093/ecco-jcc/jjv221 CrossRef

36.

Hoffmann P, Wehling C, Krisam J, Pfeiffenberger J, Belling N, Gauss A (2019) Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. World J Gastroenterol WJG 25(13):1603–1617. https://doi.org/10.3748/wjg.v25.i13.1603 CrossRefPubMed

37.

Williams JG, Alam MF, Alrubaiy L, Arnott I, Clement C, Cohen D, Gordon JN, Hawthorne AB, Hilton M, Hutchings HA, Jawhari AU, Longo M, Mansfield J, Morgan JM, Rapport F, Seagrove AC, Sebastian S, Shaw I, Travis SP, Watkins A (2016) Infliximab vs ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol 1(1):15–24. https://doi.org/10.1016/S2468-1253(16)30003-6 CrossRefPubMedPubMedCentral

38.

Narula N, Cooray M, Anglin R, Marshall J (2016) Impact of high dose vitamin d3 supplementation in treatment of Crohn's disease in remission: a randomized double-blind controlled study. In: Inflammatory bowel diseases Conference: 2015 advances in inflammatory bowel diseases, crohn's and colitis foundation's national clinical and research conference, AIBD 2015 orlando, FL united states Conference start: 20151210 conference end: 20151212 Conference publication: (varpagings) 22:S29–s30. https://doi.org/10.1097/01.MIB.0000480168.31416.a6

39.

Ordás I, Domènech E, Mañosa M, García-Sánchez V, Iglesias-Flores E, Peñalva M, Cañas-Ventura A, Merino O, Fernández-Bañares F, Gomollón F, Vera M, Gutiérrez A, Garcia-Planella E, Chaparro M, Aguas M, Gento E, Muñoz F, Aguirresarobe M, Muñoz C, Fernández L, Calvet X, Jiménez CE, Montoro MA, Mir A, De Castro ML, García-Sepulcre MF, Bermejo F, Panés J, Esteve M (2017) Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA Registry (1989–2013): a nationwide multicenter study. Am J Gastroenterol 112(11):1709–1718. https://doi.org/10.1038/ajg.2017.180 CrossRefPubMed

40.

Randall J, Singh B, Warren BF, Travis SP, Mortensen NJ, George BD (2010) Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg 97(3):404–409. https://doi.org/10.1002/bjs.6874 CrossRefPubMed

41.

Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE (2008) Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 134(3):680–687. https://doi.org/10.1053/j.gastro.2008.01.004 CrossRefPubMed

42.

Roberts SE, Williams JG, Yeates D, Goldacre MJ (2007) Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 335(7628):1033. https://doi.org/10.1136/bmj.39345.714039.55 CrossRefPubMedPubMedCentral

43.

Travis S, Satsangi J, Lémann M (2011) Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers. Gut 60(1):3–9. https://doi.org/10.1136/gut.2010.216895 CrossRefPubMed

44.

Narula N, Marshall JK, Colombel JF, Leontiadis GI, Williams JG, Muqtadir Z, Reinisch W (2016) Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids. Am J Gastroenterol 111(4):477–491. https://doi.org/10.1038/ajg.2016.7 CrossRefPubMed

45.

Bartels SA, Gardenbroek TJ, Ubbink DT, Buskens CJ, Tanis PJ, Bemelman WA (2013) Systematic review and meta-analysis of laparoscopic vs open colectomy with end ileostomy for non-toxic colitis. Br J Surg 100(6):726–733. https://doi.org/10.1002/bjs.9061 CrossRefPubMed

46.

Bartels SA, Vlug MS, Henneman D, Ponsioen CY, Tanis PJ, Bemelman WA (2012) Less adhesiolysis and hernia repair during completion proctocolectomy after laparoscopic emergency colectomy for ulcerative colitis. Surg Endosc 26(2):368–373. https://doi.org/10.1007/s00464-011-1880-1 CrossRefPubMed

47.

Maggiori L, Panis Y (2013) Surgical management of IBD–from an open to a laparoscopic approach. Nat Rev Gastroenterol Hepatol 10(5):297–306. https://doi.org/10.1038/nrgastro.2013.30 CrossRefPubMed

48.

Stewart D, Chao A, Kodner I, Birnbaum E, Fleshman J, Dietz D (2009) Subtotal colectomy for toxic and fulminant colitis in the era of immunosuppressive therapy. Colorectal Dis 11(2):184–190. https://doi.org/10.1111/j.1463-1318.2008.01579.x CrossRefPubMed

49.

Strong SA (2010) Management of acute colitis and toxic megacolon. Clin Colon Rectal Surg 23(4):274–284. https://doi.org/10.1055/s-0030-1268254 CrossRefPubMedPubMedCentral

50.

Autenrieth DM, Baumgart DC (2012) Toxic megacolon. Inflamm Bowel Dis 18(3):584–591. https://doi.org/10.1002/ibd.21847 CrossRefPubMed

51.

Gan SI, Beck PL (2003) A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 98(11):2363–2371. https://doi.org/10.1111/j.1572-0241.2003.07696.x CrossRefPubMed

52.

Greenstein AJ, Barth JA, Sachar DB, Aufses AH (1986) Free colonic perforation without dilatation in ulcerative colitis. Am J Surg 152(3):272–275. https://doi.org/10.1016/0002-9610(86)90256-4 CrossRefPubMed

53.

Mege D, Monsinjon M, Zappa M, Stefanescu C, Treton X, Maggiori L, Bouhnik Y, Panis Y (2017) Is abdominal CT useful for the management of patients with severe acute colitis complicating inflammatory bowel disease? A study in 54 consecutive patients. Colorectal Dis 19(4):O97–O102. https://doi.org/10.1111/codi.13640 CrossRefPubMed

54.

Farmer RG, Easley KA, Rankin GB (1993) Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Digest Dis Sci 38(6):1137–1146. https://doi.org/10.1007/bf01295733 CrossRefPubMed

55.

Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV, EaNHTFotIOotSoIB D (2013) A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease. Inflamm Bowel Dis 19(9):2001–2010. https://doi.org/10.1097/MIB.0b013e318281f3bb CrossRefPubMed

56.

Devaraj B, Kaiser AM (2015) Surgical management of ulcerative colitis in the era of biologicals. Inflamm Bowel Dis 21(1):208–220. https://doi.org/10.1097/MIB.0000000000000178 CrossRefPubMed

57.

Tekkis PP, Lovegrove RE, Tilney HS, Smith JJ, Sagar PM, Shorthouse AJ, Mortensen NJ, Nicholls RJ (2010) Long-term failure and function after restorative proctocolectomy—a multi-centre study of patients from the UK National Ileal Pouch Registry. Colorectal Dis 12(5):433–441. https://doi.org/10.1111/j.1463-1318.2009.01816.x CrossRefPubMed

58.

Burns EM, Bottle A, Aylin P, Clark SK, Tekkis PP, Darzi A, Nicholls RJ, Faiz O (2011) Volume analysis of outcome following restorative proctocolectomy. Br J Surg 98(3):408–417. https://doi.org/10.1002/bjs.7312 CrossRefPubMed

59.

Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ (2012) Ulcerative colitis. Lancet 380(9853):1606–1619. https://doi.org/10.1016/S0140-6736(12)60150-0 CrossRefPubMed

60.

Pellino G, Sciaudone G, Canonico S, Selvaggi F (2012) Role of ileostomy in restorative proctocolectomy. World J Gastroenterol WJG 18(15):1703–1707. https://doi.org/10.3748/wjg.v18.i15.1703 CrossRefPubMed

61.

Mowschenson PM, Critchlow JF, Peppercorn MA (2000) Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 135(4):463–465. https://doi.org/10.1001/archsurg.135.4.463(discussion 465–466) CrossRefPubMed

62.

Weston-Petrides GK, Lovegrove RE, Tilney HS, Heriot AG, Nicholls RJ, Mortensen NJ, Fazio VW, Tekkis PP (2008) Comparison of outcomes after restorative proctocolectomy with or without defunctioning ileostomy. Arch Surg 143(4):406–412. https://doi.org/10.1001/archsurg.143.4.406 CrossRefPubMed

63.

Peyrin-Biroulet L, Germain A, Patel AS, Lindsay JO (2016) Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis. Aliment Pharmacol Ther 44(8):807–816. https://doi.org/10.1111/apt.13763 CrossRefPubMed

64.

McLaughlin SD, Clark SK, Tekkis PP, Ciclitira PJ, Nicholls RJ (2008) Review article: restorative proctocolectomy, indications, management of complications and follow-up—a guide for gastroenterologists. Aliment Pharmacol Ther 27(10):895–909. https://doi.org/10.1111/j.1365-2036.2008.03643.x CrossRefPubMed

65.

Remzi FH, Preen M (2003) Rectal cancer and ulcerative colitis: does it change the therapeutic approach? Colorectal Dis 5(5):483–485CrossRefPubMed

66.

Rottoli M, Tanzanu M, Di Candido F, Colombo F, Frontali A, Chandrasinghe PC, Pellino G, Frasson M, Warusavitarne J, Panis Y, Sampietro GM, Spinelli A, Poggioli G (2019) Risk factors for locally advanced cancer associated with ulcerative colitis: results of a retrospective multicentric study in the era of biologics. Dig Liver Dis. https://doi.org/10.1016/j.dld.2019.08.024 CrossRefPubMed

67.

Pellino G, Marcellinaro R, Sciaudone G, Reginelli A, Esposito P, Riegler G, Canonico S, Villanacci V, Selvaggi F (2016) Large bowel cancer in the setting of inflammatory bowel disease: features and management with a focus on rectal cancer. Eur Surg Acta Chirurgica Austriaca 48(4):191–202. https://doi.org/10.1007/s10353-016-0434-0 CrossRef

68.

Wu XR, Kiran RP, Remzi FH, Katz S, Mukewar S, Shen B (2013) Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer. J Crohn's Colitis 7(10):e419–426. https://doi.org/10.1016/j.crohns.2013.01.017 CrossRef

69.

de Zeeuw S, Ahmed Ali U, Ali UA, Donders RA, Hueting WE, Keus F, van Laarhoven CJ (2012) Update of complications and functional outcome of the ileo-pouch anal anastomosis: overview of evidence and meta-analysis of 96 observational studies. Int J Colorectal Dis 27(7):843–853. https://doi.org/10.1007/s00384-011-1402-6 CrossRefPubMedPubMedCentral

70.

Worley GHT, Fearnhead NS, Brown SR, Acheson AG, Lee MJ, Faiz OD, Association of Coloproctology of Great Britain, and Ireland (ACPGBI) Inflammatory Bowel Disease Clinical Advisory Group citAIPR, and Ileoanal Pouch Registry contributors (2018) Review of current practice and outcomes following ileoanal pouch surgery: lessons learned from the Ileoanal Pouch Registry and the 2017 Ileoanal Pouch Report. Colorectal Dis 20(10):913–922. https://doi.org/10.1111/codi.14316 CrossRefPubMed

71.

Colombo F, Pellino G, Sampietro G, Selvaggi F, Canonico S, Foschi D (2018) Surgical treatment of inflammatory bowel diseases in the elderly. In: Crucitti A (eds) Surgical management of elderly patients. Springer, Cham. https://doi.org/10.1007/978-3-319-60861-7_12 CrossRef

72.

Jakobsen C, Bartek J, Wewer V, Vind I, Munkholm P, Groen R, Paerregaard A (2011) Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease—a population-based study. Aliment Pharmacol Ther 34(10):1217–1224. https://doi.org/10.1111/j.1365-2036.2011.04857.x CrossRefPubMed

73.

Berger M, Gribetz D, Korelitz BI (1975) Growth retardation in children with ulcerative colitis: the effect of medical and surgical therapy. Pediatrics 55(4):459–467PubMed

74.

Griffiths AM (2009) Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently? Dig Dis 27(3):404–411. https://doi.org/10.1159/000228581 CrossRefPubMed

75.

Heuschkel R, Salvestrini C, Beattie RM, Hildebrand H, Walters T, Griffiths A (2008) Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 14(6):839–849. https://doi.org/10.1002/ibd.20378 CrossRefPubMed

76.

Lightner AL, Alsughayer A, Wang Z, McKenna NP, Seisa MO, Moir C (2019) Short- and long-term outcomes after ileal pouch anal anastomosis in pediatric patients: a systematic review. Inflamm Bowel Dis 25(7):1152–1168. https://doi.org/10.1093/ibd/izy375 CrossRefPubMed

77.

Pellino G, Sciaudone G, Miele E, Candilio G, De Fatico GS, Riegler G, Staiano A, Canonico S, Selvaggi F (2014) Functional outcomes and quality of life after restorative proctocolectomy in paediatric patients: a case–control study. Gastroenterol Res Pract 2014:340341. https://doi.org/10.1155/2014/340341 CrossRefPubMedPubMedCentral

78.

Mattioli G, Barabino A, Aloi M, Arrigo S, Caldaro T, Carlucci M, Cucchiara S, De Angelis P, Di Leo G, Illiceto MT, Impellizzeri P, Leonelli L, Lisi G, Lombardi G, Martelossi S, Martinelli M, Miele E, Randazzo A, Romano C, Romeo C, Romeo E, Selvaggi F, Valenti S, Dall'Oglio L (2015) Paediatric ulcerative colitis surgery: Italian survey. J Crohn's Colitis 9(7):558–564. https://doi.org/10.1093/ecco-jcc/jjv065 CrossRef

79.

Nguyen DL, Solaimani P, Nguyen ET, Jamal MM, Bechtold ML (2014) Antitumor necrosis factor α is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn's disease: a meta-analysis. Eur J Gastroenterol Hepatol 26(10):1152–1159. https://doi.org/10.1097/MEG.0000000000000178 CrossRefPubMed

80.

Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR (2003) Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125(2):320–327. https://doi.org/10.1016/s0016-5085(03)00883-7 CrossRefPubMed

81.

Sampietro GM, Colombo F, Frontali A, Baldi CM, Carmagnola S, Cassinotti A, Dell'Era A, Massari A, Molteni P, Dilillo D, Fociani P, Tonolini M, Maconi G, Fiorina P, Corsi F, Bianco R, Nebuloni M, Zuccotti G, Ardizzone S, Foschi D (2018) Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term results. Dig Liver Dis 50(12):1283–1291. https://doi.org/10.1016/j.dld.2018.05.009 CrossRefPubMed

82.

Subramanian V, Saxena S, Kang JY, Pollok RC (2008) Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 103(9):2373–2381. https://doi.org/10.1111/j.1572-0241.2008.01942.x CrossRefPubMed

83.

Ferrante M, D'Hoore A, Vermeire S, Declerck S, Noman M, Van Assche G, Hoffman I, Rutgeerts P, Penninckx F (2009) Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 15(7):1062–1070. https://doi.org/10.1002/ibd.20863 CrossRefPubMed

84.

Sahami S, Bartels SA, D'Hoore A, Fadok TY, Tanis PJ, Lindeboom R, van Overstraeten AB, Wolthuis AM, Bemelman WA, Buskens CJ (2016) A multicentre evaluation of risk factors for anastomotic leakage after restorative proctocolectomy with ileal pouch–anal anastomosis for inflammatory bowel disease. J Crohn's Colitis 10(7):773–778. https://doi.org/10.1093/ecco-jcc/jjv170 CrossRef

85.

Hartman C, Eliakim R, Shamir R (2009) Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol WJG 15(21):2570–2578. https://doi.org/10.3748/wjg.15.2570 CrossRefPubMed

86.

Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schütz T, van Gemert W, van Gossum A, Valentini L, Lübke H, Bischoff S, Engelmann N, Thul P, Medicine (DGSfN, Nutrition) EESfPaE (2006) ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr 25(2):260–274. https://doi.org/10.1016/j.clnu.2006.01.007 CrossRefPubMed

87.

Gu J, Stocchi L, Remzi F, Kiran RP (2013) Factors associated with postoperative morbidity, reoperation and readmission rates after laparoscopic total abdominal colectomy for ulcerative colitis. Colorectal Dis 15(9):1123–1129. https://doi.org/10.1111/codi.12267 CrossRefPubMed

88.

Markel TA, Lou DC, Pfefferkorn M, Scherer LR, West K, Rouse T, Engum S, Ladd A, Rescorla FJ, Billmire DF (2008) Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery 144(4):540–545. https://doi.org/10.1016/j.surg.2008.07.005(discussion 545–547) CrossRefPubMed

89.

Oresland T, Palmblad S, Ellström M, Berndtsson I, Crona N, Hultén L (1994) Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis 9(2):77–81CrossRefPubMed

90.

Ørding Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S (2002) Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 122(1):15–19. https://doi.org/10.1053/gast.2002.30345 CrossRefPubMed

91.

Gorgun E, Remzi FH, Goldberg JM, Thornton J, Bast J, Hull TL, Loparo B, Fazio VW (2004) Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery 136(4):795–803. https://doi.org/10.1016/j.surg.2004.06.018 CrossRefPubMed

92.

El Hussuna A, Myrelid P, Holubar S, Kotze P, Mackenzie G, Pellino G, Winter D, Davies J, Negoi I, Grewal P, Gallo G, Sahnan K, Rubio-Perez I, Clerc D, Demartines N, Glasbey J, Regueiro M, Sherif A, Neary P, Pata F, Silverberg M, Clermont S, Chadi S, Emile S, Buchs N, Millan M, Minaya-Bravo A, Elfeki H, De Simone V, Shalaby M, Gutierrez C, Ozen C, Yalçınkaya A, Rivadeneira D, Sturiale A, Yassin N, Spinelli A, Warusavitarne J, Ioannidis A, Wexner S, Mayol J (2019) Biological treatment and the potential risk of adverse postoperative outcome in patients with inflammatory bowel disease: an open source expert panel review of the current literature and future perspectives. Crohn's Colitis. https://doi.org/10.1093/crocol/otz021 CrossRef

93.

Selvaggi F, Pellino G, Canonico S, Sciaudone G (2015) Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis. Inflamm Bowel Dis 21(1):79–92. https://doi.org/10.1097/MIB.0000000000000232 CrossRefPubMed

94.

Mor IJ, Vogel JD, da Luz Moreira A, Shen B, Hammel J, Remzi FH (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum. 51:1202–1207. https://doi.org/10.1007/s10350-008-9364-7 CrossRefPubMed

95.

Gainsbury ML, Chu DI, Howard LA, Coukos JA, Farraye FA, Stucchi AF, Becker JM (2011) Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch–anal anastomosis. J Gastrointest Surg 15(3):397–403. https://doi.org/10.1007/s11605-010-1385-6 CrossRefPubMed

96.

Bregnbak D, Mortensen C, Bendtsen F (2012) Infliximab and complications after colectomy in patients with ulcerative colitis. J Crohn's Colitis 6(3):281–286. https://doi.org/10.1016/j.crohns.2011.08.014 CrossRef

97.

Billioud V, Ford AC, Tedesco ED, Colombel JF, Roblin X, Peyrin-Biroulet L (2013) Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohn's Colitis 7(11):853–867. https://doi.org/10.1016/j.crohns.2013.01.014 CrossRef

98.

Yang Z, Wu Q, Wu K, Fan D (2010) Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 31(4):486–492. https://doi.org/10.1111/j.1365-2036.2009.04204.x CrossRefPubMed

99.

Kulaylat AS, Kulaylat AN, Schaefer EW, Tinsley A, Williams E, Koltun W, Hollenbeak CS, Messaris E (2017) Association of preoperative anti-tumor necrosis factor therapy with adverse postoperative outcomes in patients undergoing abdominal surgery for ulcerative colitis. JAMA Surg 152(8):e171538. https://doi.org/10.1001/jamasurg.2017.1538 CrossRefPubMedPubMedCentral

100.

Lightner AL, Tse CS, Potter DD, Moir C (2018) Postoperative outcomes in vedolizumab-treated pediatric patients undergoing abdominal operations for inflammatory bowel disease. J Pediatr Surg 53(9):1706–1709. https://doi.org/10.1016/j.jpedsurg.2017.09.019 CrossRefPubMed

101.

Shah ED, Farida JP, Siegel CA, Chong K, Melmed GY (2017) Risk for overall infection with anti-TNF and anti-integrin agents used in IBD: a systematic review and meta-analysis. Inflamm Bowel Dis 23(4):570–577. https://doi.org/10.1097/MIB.0000000000001049 CrossRefPubMed

102.

Fleming FJ, Francone TD, Kim MJ, Gunzler D, Messing S, Monson JR (2011) A laparoscopic approach does reduce short-term complications in patients undergoing ileal pouch–anal anastomosis. Dis Colon Rectum 54(2):176–182. https://doi.org/10.1007/DCR.0b013e3181fb4232 CrossRefPubMed

103.

Bartels SA, D’hoore A, Cuesta MA, Bensdorp AJ, Lucas C, Bemelman WA (2012) Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg 256(6):1045–1048. https://doi.org/10.1097/SLA.0b013e318250caa9 CrossRefPubMed

104.

Mege D, Frontali A, Pellino G, Adegbola S, Maggiori L, Warusavitarne J, Panis Y (2019) Laparoscopic subtotal colectomy with double-end ileosigmoidostomy in right iliac fossa facilitates second-stage surgery in patients with inflammatory bowel disease. Surg Endosc. https://doi.org/10.1007/s00464-019-06749-3 CrossRefPubMed

105.

Lightner AL, Kelley SR, Larson DW (2018) Robotic platform for an IPAA. Dis Colon Rectum 61(7):869–874. https://doi.org/10.1097/DCR.0000000000001125 CrossRefPubMed

106.

Lightner AL, Grass F, McKenna NP, Tilman M, Alsughayer A, Kelley SR, Behm K, Merchea A, Larson DW (2019) Short-term postoperative outcomes following robotic vs laparoscopic ileal pouch–anal anastomosis are equivalent. Tech Coloproctol 23(3):259–266. https://doi.org/10.1007/s10151-019-01953-8 CrossRefPubMed

107.

van Overstraeten AB, Mark-Christensen A, Wasmann KA, Bastiaenen VP, Buskens CJ, Wolthuis AM, Vanbrabant K, D’Hoore A, Bemelman WA, Tottrup A, Tanis PJ (2017) Transanal vs transabdominal minimally invasive (completion) proctectomy with ileal pouch–anal anastomosis in ulcerative colitis: a comparative study. Ann Surg 266(5):878–883. https://doi.org/10.1097/SLA.0000000000002395 CrossRef

108.

Zaghiyan K, Warusavitarne J, Spinelli A, Chandrasinghe P, Di Candido F, Fleshner P (2018) Technical variations and feasibility of transanal ileal pouch–anal anastomosis for ulcerative colitis and inflammatory bowel disease unclassified across continents. Tech Coloproctol 22(11):867–873. https://doi.org/10.1007/s10151-018-1889-8 CrossRefPubMed

109.

Sahnan K, Pellino G, Adegbola SO, Tozer PJ, Chandrasinghe P, Miskovic D, Hompes R, Warusavitarne J, Lung PFC (2018) Development of a model of three-dimensional imaging for the preoperative planning of TaTME. Tech Coloproctol 22(1):59–63. https://doi.org/10.1007/s10151-017-1724-7 CrossRefPubMed

110.

Keller DS, Reali C, Spinelli A, Penna M, Di Candido F, Cunningham C, Hompes R (2019) Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision. Br J Surg 106(4):364–366. https://doi.org/10.1002/bjs.11069 CrossRefPubMed

111.

Nicholls RJ, Pezim ME (1985) Restorative proctocolectomy with ileal reservoir for ulcerative colitis and familial adenomatous polyposis: a comparison of three reservoir designs. Br J Surg 72(6):470–474CrossRefPubMed

112.

Lovegrove RE, Heriot AG, Constantinides V, Tilney HS, Darzi AW, Fazio VW, Nicholls RJ, Tekkis PP (2007) Meta-analysis of short-term and long-term outcomes of J, W and S ileal reservoirs for restorative proctocolectomy. Colorectal Dis 9(4):310–320. https://doi.org/10.1111/j.1463-1318.2006.01093.x CrossRefPubMed

113.

Simillis C, Afxentiou T, Pellino G, Kontovounisios C, Rasheed S, Faiz O, Tekkis PP (2018) A systematic review and meta-analysis comparing adverse events and functional outcomes of different pouch designs after restorative proctocolectomy. Colorectal Dis 20(8):664–675. https://doi.org/10.1111/codi.14104 CrossRefPubMed

114.

Selvaggi F, Giuliani A, Gallo C, Signoriello G, Riegler G, Canonico S (2000) Randomized, controlled trial to compare the J-pouch and W-pouch configurations for ulcerative colitis in the maturation period. Dis Colon Rectum 43(5):615–620CrossRefPubMed

115.

de Silva HJ, de Angelis CP, Soper N, Kettlewell MG, Mortensen NJ, Jewell DP (1991) Clinical and functional outcome after restorative proctocolectomy. Br J Surg 78(9):1039–1044. https://doi.org/10.1002/bjs.1800780905 CrossRefPubMed

116.

Johnston D, Williamson ME, Lewis WG, Miller AS, Sagar PM, Holdsworth PJ (1996) Prospective controlled trial of duplicated (J) vs quadruplicated (W) pelvic ileal reservoirs in restorative proctocolectomy for ulcerative colitis. Gut 39(2):242–247. https://doi.org/10.1136/gut.39.2.242 CrossRefPubMedPubMedCentral

117.

Uraiqat AA, Byrne CM, Phillips RK (2007) Gaining length in ileal-anal pouch reconstruction: a review. Colorectal Dis 9(7):657–661. https://doi.org/10.1111/j.1463-1318.2006.01181.x CrossRefPubMed

118.

Selvaggi F, Pellino G (2015) Pouch-related fistula and intraoperative tricks to prevent it. Tech Coloproctol 19(2):63–67. https://doi.org/10.1007/s10151-014-1257-2 CrossRefPubMed

119.

Pescatori M (1988) A modified three-loop ileoanal reservoir. Dis Colon Rectum 31(10):823–824. https://doi.org/10.1007/bf02560118 CrossRefPubMed

120.

Tulchinsky H, McCourtney JS, Rao KV, Chambers W, Williams J, Wilkinson KH, Nicholls RJ (2001) Salvage abdominal surgery in patients with a retained rectal stump after restorative proctocolectomy and stapled anastomosis. Br J Surg 88(12):1602–1606. https://doi.org/10.1046/j.0007-1323.2001.01931.x CrossRefPubMed

121.

Tulchinsky H, Cohen CR, Nicholls RJ (2003) Salvage surgery after restorative proctocolectomy. Br J Surg 90(8):909–921. https://doi.org/10.1002/bjs.4278 CrossRefPubMed

122.

Pellino G, Selvaggi F (2015) Outcomes of salvage surgery for ileal pouch complications and dysfunctions The experience of a referral centre and review of literature. J Crohn's Colitis 9(7):548–557. https://doi.org/10.1093/ecco-jcc/jjv066 CrossRef

123.

Reilly WT, Pemberton JH, Wolff BG, Nivatvongs S, Devine RM, Litchy WJ, McIntyre PB (1997) Randomized prospective trial comparing ileal pouch–anal anastomosis performed by excising the anal mucosa to ileal pouch–anal anastomosis performed by preserving the anal mucosa. Ann Surg 225(6):666–676. https://doi.org/10.1097/00000658-199706000-00004(discussion 676–667) CrossRefPubMedPubMedCentral

124.

Selvaggi F, Pellino G, Canonico S, Sciaudone G (2012) Is omitting pouchography before ileostomy takedown safe after negative clinical examination in asymptomatic patients with pelvic ileal pouch? An observational study. Tech Coloproctol 16(6):415–420. https://doi.org/10.1007/s10151-012-0838-1 CrossRefPubMed

125.

Santorelli C, Hollingshead J, Clark SK (2018) Clinical value of pouchogram prior to ileostomy closure after ileal pouch anal anastomosis. Tech Coloproctol 22(7):541–544. https://doi.org/10.1007/s10151-018-1823-0 CrossRefPubMed

126.

McGuire BB, Brannigan AE, O'Connell PR (2007) Ileal pouch–anal anastomosis. Br J Surg 94(7):812–823. https://doi.org/10.1002/bjs.5866 CrossRefPubMed

127.

Selvaggi F, Sciaudone G, Limongelli P, Di Stazio C, Guadagni I, Pellino G, De Rosa M, Riegler G (2010) The effect of pelvic septic complications on function and quality of life after ileal pouch–anal anastomosis: a single center experience. Am Surg 76(4):428–435PubMed

128.

Sagar PM, Pemberton JH (2012) Intraoperative, postoperative and reoperative problems with ileoanal pouches. Br J Surg 99(4):454–468. https://doi.org/10.1002/bjs.8697 CrossRefPubMed

129.

Sagar PM, Pemberton JH (1997) Ileo-anal pouch function and dysfunction. Dig Dis 15(3):172–188. https://doi.org/10.1159/000171597 CrossRefPubMed

130.

Scott NA, Dozois RR, Beart RW, Pemberton JH, Wolff BG, Ilstrup DM (1988) Postoperative intra-abdominal and pelvic sepsis complicating ileal pouch–anal anastomosis. Int J Colorectal Dis 3(3):149–152CrossRefPubMed

131.

Bach SP, Mortensen NJ (2006) Revolution and evolution: 30 years of ileoanal pouch surgery. Inflamm Bowel Dis 12(2):131–145. https://doi.org/10.1097/01.MIB.0000197547.80558.59 CrossRefPubMed

132.

Worley GHT, Segal JP, Warusavitarne J, Clark SK, Faiz OD (2018) Management of early pouch-related septic complications in ulcerative colitis: a systematic review. Colorectal Dis 20(8):O181–O189. https://doi.org/10.1111/codi.14266 CrossRefPubMed

133.

Lian L, Serclova Z, Fazio VW, Kiran RP, Remzi F, Shen B (2008) Clinical features and management of postoperative pouch bleeding after ileal pouch–anal anastomosis (IPAA). J Gastrointest Surg 12(11):1991–1994. https://doi.org/10.1007/s11605-008-0611-y CrossRefPubMed

134.

Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK (1995) Ileal pouch–anal anastomoses complications and function in 1005 patients. Ann Surg 222(2):120–127CrossRefPubMedPubMedCentral

135.

Lovegrove RE, Constantinides VA, Heriot AG, Athanasiou T, Darzi A, Remzi FH, Nicholls RJ, Fazio VW, Tekkis PP (2006) A comparison of hand-sewn vs stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy: a meta-analysis of 4183 patients. Ann Surg 244(1):18–26. https://doi.org/10.1097/01.sla.0000225031.15405.a3 CrossRefPubMedPubMedCentral

136.

Segal JP, Adegbola SO, Worley GHT, Sahnan K, Tozer P, Lung PFC, Faiz OD, Clark SK, Hart AL (2018) A systematic review: the management and outcomes of ileal pouch strictures. J Crohn's Colitis 12(3):369–375. https://doi.org/10.1093/ecco-jcc/jjx151 CrossRef

137.

Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR (2007) Results at up to 20 years after ileal pouch–anal anastomosis for chronic ulcerative colitis. Br J Surg 94(3):333–340. https://doi.org/10.1002/bjs.5464 CrossRefPubMed

138.

Kong E, Nikolaou S, Qiu S, Pellino G, Tekkis P, Kontovounisios C (2018) A systematic review of sacral nerve stimulation for faecal incontinence following ileal pouch anal anastomosis. Updates Surg 70(1):1–5. https://doi.org/10.1007/s13304-017-0496-y CrossRefPubMed

139.

Bartels SA, Gardenbroek TJ, Aarts M, Ponsioen CY, Tanis PJ, Buskens CJ, Bemelman WA (2015) Short-term morbidity and quality of life from a randomized clinical trial of close rectal dissection and total mesorectal excision in ileal pouch–anal anastomosis. Br J Surg 102(3):281–287. https://doi.org/10.1002/bjs.9701 CrossRefPubMed

140.

Lindsey I, George BD, Kettlewell MG, Mortensen NJ (2001) Impotence after mesorectal and close rectal dissection for inflammatory bowel disease. Dis Colon Rectum 44(6):831–835. https://doi.org/10.1007/bf02234703 CrossRefPubMed

141.

Selvaggi F, Pellino G, Canonico S, Sciaudone G (2014) Systematic review of cuff and pouch cancer in patients with ileal pelvic pouch for ulcerative colitis. Inflamm Bowel Dis 20:1296–1308CrossRefPubMed

142.

M'Koma AE, Moses HL, Adunyah SE (2011) Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis 26(5):533–552. https://doi.org/10.1007/s00384-011-1137-4 CrossRefPubMedPubMedCentral

143.

Derikx LAAP, Nissen LHC, Smits LJT, Shen B, Hoentjen F (2016) Risk of neoplasia after colectomy in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 14(6):798–806.e720. https://doi.org/10.1016/j.cgh.2015.08.042 CrossRefPubMed

144.

Egan L, D'Inca R, Jess T, Pellino G, Carbonnel F, Bokemeyer B, Harbord M, Nunes P, Van der Woude J, Selvaggi F, Triantafillidis J (2014) Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II). J Crohn's Colitis 8(1):19–30. https://doi.org/10.1016/j.crohns.2013.04.009 CrossRef

145.

Annese V, Beaugerie L, Egan L, Biancone L, Bolling C, Brandts C, Dierickx D, Dummer R, Fiorino G, Gornet JM, Higgins P, Katsanos KH, Nissen L, Pellino G, Rogler G, Scaldaferri F, Szymanska E, Eliakim R, ECCO (2015) European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohn's Colitis. https://doi.org/10.1093/ecco-jcc/jjv141 CrossRef

146.

Pellino G, Kontovounisios C, Tait D, Nicholls J, Tekkis PP (2017) Squamous cell carcinoma of the anal transitional zone after ileal pouch surgery for ulcerative colitis: systematic review and treatment perspectives. Case Rep Oncol 10(1):112–122. https://doi.org/10.1159/000455898 CrossRefPubMedPubMedCentral

147.

Scarpa M, van Koperen PJ, Ubbink DT, Hommes DW, Ten Kate FJ, Bemelman WA (2007) Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg 94(5):534–545. https://doi.org/10.1002/bjs.5811 CrossRefPubMed

148.

Li Y, Shen B (2012) Evaluating pouch problems. Gastroenterol Clin N Am 41(2):355–378. https://doi.org/10.1016/j.gtc.2012.01.013 CrossRef

149.

Kiely JM, Fazio VW, Remzi FH, Shen B, Kiran RP (2012) Pelvic sepsis after IPAA adversely affects function of the pouch and quality of life. Dis Colon Rectum 55(4):387–392. https://doi.org/10.1097/DCR.0b013e318246418e CrossRefPubMed

150.

Gardenbroek TJ, Musters GD, Buskens CJ, Ponsioen CY, D'Haens GR, Dijkgraaf MG, Tanis PJ, Bemelman WA (2015) Early reconstruction of the leaking ileal pouch–anal anastomosis: a novel solution to an old problem. Colorectal Dis 17(5):426–432. https://doi.org/10.1111/codi.12867 CrossRefPubMed

151.

Rottoli M, Di Simone MP, Vallicelli C, Vittori L, Liguori G, Boschi L, Poggioli G (2018) Endoluminal vacuum-assisted therapy as treatment for anastomotic leak after ileal pouch–anal anastomosis: a pilot study. Tech Coloproctol 22(3):223–229. https://doi.org/10.1007/s10151-018-1762-9 CrossRefPubMed

152.

Wasmann KA, Reijntjes MA, Stellingwerf ME, Ponsioen CY, Buskens CJ, Hompes R, Tanis PJ, Bemelman WA (2019) Endo-sponge assisted earlysurgical closure of ileal pouch-anal anastomotic leakage preserves long-term function: a cohort study. J Crohns Colitis 13:1537–1545. https://doi.org/10.1093/ecco-jcc/jjz093 CrossRefPubMedPubMedCentral

153.

Remzi FH, Aytac E, Ashburn J, Gu J, Hull TL, Dietz DW, Stocchi L, Church JM, Shen B (2015) Transabdominal redo ileal pouch surgery for failed restorative proctocolectomy: lessons learned over 500 patients. Ann Surg 262(4):675–682. https://doi.org/10.1097/SLA.0000000000001386 CrossRefPubMed

154.

Rottoli M, Vallicelli C, Gionchetti P, Rizzello F, Boschi L, Poggioli G (2018) Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study. Dig Liver Dis 50(5):446–451. https://doi.org/10.1016/j.dld.2017.11.011 CrossRefPubMed

155.

Doeksen A, Gooszen JA, van Duijvendijk P, Tanis PJ, Bakx R, Slors JF, van Lanschot JJ (2011) Sexual and urinary functioning after rectal surgery: a prospective comparative study with a median follow-up of 8.5 years. Int J Colorectal Dis 26(12):1549–1557. https://doi.org/10.1007/s00384-011-1288-3 CrossRefPubMedPubMedCentral

156.

Davies RJ, O'Connor BI, Victor C, MacRae HM, Cohen Z, McLeod RS (2008) A prospective evaluation of sexual function and quality of life after ileal pouch–anal anastomosis. Dis Colon Rectum 51(7):1032–1035. https://doi.org/10.1007/s10350-008-9248-x CrossRefPubMed

157.

Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS (2011) Impact of ileal pouch–anal anastomosis on female fertility: meta-analysis and systematic review. Int J Colorectal Dis 26(11):1365–1374. https://doi.org/10.1007/s00384-011-1274-9 CrossRefPubMed

158.

Waljee A, Waljee J, Morris AM, Higgins PD (2006) Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 55(11):1575–1580. https://doi.org/10.1136/gut.2005.090316 CrossRefPubMedPubMedCentral

159.

Andersson M, Jensen MB, Engholm G, Henrik Storm H (2008) Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977–2001. Acta Oncol (Stockholm, Sweden) 47(4):755–764. https://doi.org/10.1080/02841860801978921 CrossRef

160.

Pachler FR, Brandsborg SB, Laurberg S (2017) Paradoxical impact of ileal pouch–anal anastomosis on male and female fertility in patients with ulcerative colitis. Dis Colon Rectum 60(6):603–607. https://doi.org/10.1097/DCR.0000000000000796 CrossRefPubMed

161.

Beyer-Berjot L, Maggiori L, Birnbaum D, Lefevre JH, Berdah S, Panis Y (2013) A total laparoscopic approach reduces the infertility rate after ileal pouch–anal anastomosis: a 2-center study. Ann Surg 258(2):275–282. https://doi.org/10.1097/SLA.0b013e3182813741 CrossRefPubMed

162.

Gorgun E, Cengiz TB, Aytac E, Aiello A, da Silva G, Goldberg JM, Holubar SD, Stocchi L, Wexner SD, Steele SR, Hull TL (2019) Does laparoscopic ileal pouch–anal anastomosis reduce infertility compared with open approach? Surgery 166(4):670–677. https://doi.org/10.1016/j.surg.2019.04.045 CrossRefPubMed

163.

McLeod RS, Baxter NN (1998) Quality of life of patients with inflammatory bowel disease after surgery. World J Surg 22(4):375–381. https://doi.org/10.1007/s002689900400 CrossRefPubMed

164.

WHOQOL (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41(10):1403–1409. https://doi.org/10.1016/0277-9536(95)00112-k CrossRef

165.

Heikens JT, de Vries J, van Laarhoven CJ (2012) Quality of life, health-related quality of life and health status in patients having restorative proctocolectomy with ileal pouch–anal anastomosis for ulcerative colitis: a systematic review. Colorectal Dis 14(5):536–544. https://doi.org/10.1111/j.1463-1318.2010.02538.x CrossRefPubMed

166.

Hamming JF, De Vries J (2007) Measuring quality of life. Br J Surg 94(8):923–924. https://doi.org/10.1002/bjs.5948 CrossRefPubMed

167.

Murphy PB, Khot Z, Vogt KN, Ott M, Dubois L (2015) Quality of life after total proctocolectomy with ileostomy or IPAA: a systematic review. Dis Colon Rectum 58(9):899–908. https://doi.org/10.1097/DCR.0000000000000418 CrossRefPubMed

168.

Gao XH, Li JQ, Khan F, Chouhan H, Yu GY, Remer E, Stocchi L, Hull TL, Shen B (2019) Difference in the frequency of pouchitis between ulcerative colitis and familial adenomatous polyposis: is the explanation in peripouch fat? Colorectal Dis 21(9):1032–1044. https://doi.org/10.1111/codi.14651 CrossRefPubMed

169.

Samaan MA, Shen B, Mosli MH, Zou G, Sandborn WJ, Shackelton LM, Nelson S, Stitt L, Bloom S, Pardi DS, Gionchetti P, Lindsay J, Travis S, Hart A, Silverberg MS, Feagan BG, D'Haens GR, Jairath V (2018) Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointest Endosc 88(2):360–369.e362. https://doi.org/10.1016/j.gie.2018.04.2330 CrossRefPubMed

170.

van der Ploeg VA, Maeda Y, Faiz OD, Hart AL, Clark SK (2018) Standardising assessment and documentation of pouchoscopy. Frontline Gastroenterol 9(4):309–314. https://doi.org/10.1136/flgastro-2017-100928 CrossRefPubMedPubMedCentral

171.

Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollon F, Hauser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohn's Colitis 7(1):1–33. https://doi.org/10.1016/j.crohns.2012.09.005 CrossRef

172.

Delaini GG, Scaglia M, Colucci G, Hultén L (2005) The ileoanal pouch procedure in the long-term perspective: a critical review. Tech Coloproctol 9(3):187–192. https://doi.org/10.1007/s10151-005-0225-2 CrossRefPubMed

173.

Fazio VW, Kiran RP, Remzi FH, Coffey JC, Heneghan HM, Kirat HT, Manilich E, Shen B, Martin ST (2013) Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 257(4):679–685. https://doi.org/10.1097/SLA.0b013e31827d99a2 CrossRefPubMed

174.

Alexander F (2007) Complications of ileal pouch anal anastomosis. Semin Pediatr Surg 16(3):200–204. https://doi.org/10.1053/j.sempedsurg.2007.04.009 CrossRefPubMed

175.

Fazio VW, Wu JS, Lavery IC (1998) Repeat ileal pouch–anal anastomosis to salvage septic complications of pelvic pouches: clinical outcome and quality of life assessment. Ann Surg 228(4):588–597CrossRefPubMedPubMedCentral

176.

Remzi FH, Fazio VW, Kirat HT, Wu JS, Lavery IC, Kiran RP (2009) Repeat pouch surgery by the abdominal approach safely salvages failed ileal pelvic pouch. Dis Colon Rectum 52(2):198–204. https://doi.org/10.1007/DCR.0b013e31819ad4b6 CrossRefPubMed

177.

Sagar PM, Dozois RR, Wolff BG, Kelly KA (1996) Disconnection, pouch revision and reconnection of the ileal pouch–anal anastomosis. Br J Surg 83(10):1401–1405CrossRefPubMed

178.

Selvaggi F, Sciaudone G, Giuliani A, Di Stazio C, Guadagni I (2006) Salvage surgery after restorative proctocolectomy. In: Delaini G (ed) Inflammatory bowel disease and familial adenomatous polyposis. Springer, Milan, pp 273–278. https://doi.org/10.1007/88-470-0434-9_27 CrossRef

179.

Segal JP, Poo SX, McLaughlin SD, Faiz OD, Clark SK, Hart AL (2018) Long-term follow-up of the use of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis. Frontline Gastroenterol 9(2):154–158. https://doi.org/10.1136/flgastro-2017-100913 CrossRefPubMedPubMedCentral

180.

Segal JP, Oke S, Hold GL, Clark SK, Faiz OD, Hart AL (2018) Systematic review: ileoanal pouch microbiota in health and disease. Aliment Pharmacol Ther 47(4):466–477. https://doi.org/10.1111/apt.14454 CrossRefPubMed

181.

Huguet M, Pereira B, Goutte M, Goutorbe F, Dubois A, Bommelaer G, Buisson A (2018) Systematic review with meta-analysis: anti-TNF therapy in refractory pouchitis and crohn's disease-like complications of the pouch after ileal pouch–anal anastomosis following colectomy for ulcerative colitis. Inflamm Bowel Dis 24(2):261–268. https://doi.org/10.1093/ibd/izx049 CrossRefPubMed

182.

Gregory M, Weaver KN, Hoversten P, Hicks SB, Patel D, Ciorba MA, Gutierrez AM, Beniwal-Patel P, Palam S, Syal G, Herfarth HH, Christophi G, Raffals L, Barnes EL, Deepak P (2019) Efficacy of vedolizumab for refractory pouchitis of the ileo-anal pouch: results from a multicenter US Cohort. Inflamm Bowel Dis 25(9):1569–1576. https://doi.org/10.1093/ibd/izz030 CrossRefPubMedPubMedCentral

183.

Bär F, Kühbacher T, Dietrich NA, Krause T, Stallmach A, Teich N, Schreiber S, Walldorf J, Schmelz R, Büning C, Fellermann K, Büning J, Helwig U, Group GIS (2018) Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis. Aliment Pharmacol Ther 47(5):581–587. https://doi.org/10.1111/apt.14479 CrossRefPubMed

184.

Singh A, Khan F, Lopez R, Shen B, Philpott J (2019) Vedolizumab for chronic antibiotic-refractory pouchitis. Gastroenterol Rep (Oxf) 7(2):121–126. https://doi.org/10.1093/gastro/goz001 CrossRef

185.

Weaver KN, Gregory M, Syal G, Hoversten P, Hicks SB, Patel D, Christophi G, Beniwal-Patel P, Isaacs KL, Raffals L, Deepak P, Herfarth HH, Barnes EL (2019) Ustekinumab is effective for the treatment of crohn's disease of the pouch in a multicenter cohort. Inflamm Bowel Dis 25(4):767–774. https://doi.org/10.1093/ibd/izy302 CrossRefPubMed

186.

Bharadwaj S, Philpott JR, Barber MD, Graff LA, Shen B (2014) Women's health issues after ileal pouch surgery. Inflamm Bowel Dis 20(12):2470–2482. https://doi.org/10.1097/MIB.0000000000000171 CrossRefPubMed

187.

Cornish JA, Tan E, Singh B, Bundock H, Mortensen N, Nicholls RJ, Clark SK, Tekkis PP (2011) Female infertility following restorative proctocolectomy. Colorectal Dis 13(10):e339–344. https://doi.org/10.1111/j.1463-1318.2011.02694.x CrossRefPubMed

188.

Garrard CL, Clements RH, Nanney L, Davidson JM, Richards WO (1999) Adhesion formation is reduced after laparoscopic surgery. Surg Endosc 13(1):10–13. https://doi.org/10.1007/s004649900887 CrossRefPubMed

189.

Matthews JM, Kodner IJ, Fry RD, Fazio VW (1986) Entrapped ovary syndrome. Dis Colon Rectum 29(5):341–343. https://doi.org/10.1007/bf02554127 CrossRefPubMed

190.

Fazio VW, Cohen Z, Fleshman JW, van Goor H, Bauer JJ, Wolff BG, Corman M, Beart RW, Wexner SD, Becker JM, Monson JR, Kaufman HS, Beck DE, Bailey HR, Ludwig KA, Stamos MJ, Darzi A, Bleday R, Dorazio R, Madoff RD, Smith LE, Gearhart S, Lillemoe K, Göhl J (2006) Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum 49(1):1–11. https://doi.org/10.1007/s10350-005-0268-5 CrossRefPubMed

191.

Johnson P, Richard C, Ravid A, Spencer L, Pinto E, Hanna M, Cohen Z, McLeod R (2004) Female infertility after ileal pouch–anal anastomosis for ulcerative colitis. Dis Colon Rectum 47(7):1119–1126. https://doi.org/10.1007/s10350-004-0570-7 CrossRefPubMed

192.

Jain JK, Paulson RJ (2006) Oocyte cryopreservation. Fertil Steril 86(4 Suppl):1037–1046. https://doi.org/10.1016/j.fertnstert.2006.07.1478 CrossRefPubMed

193.

van der Woude CJ, Ardizzone S, Bengtson MB, Fiorino G, Fraser G, Katsanos K, Kolacek S, Juillerat P, Mulders AG, Pedersen N, Selinger C, Sebastian S, Sturm A, Zelinkova Z, Magro F, (ECCO) ftECsaCO (2014) The Second European Evidenced-Based Consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohn's Colitis. https://doi.org/10.1093/ecco-jcc/jju006 CrossRef

194.

Nelson H, Dozois RR, Kelly KA, Malkasian GD, Wolff BG, Ilstrup DM (1989) The effect of pregnancy and delivery on the ileal pouch–anal anastomosis functions. Dis Colon Rectum 32(5):384–388. https://doi.org/10.1007/bf02563689 CrossRefPubMed

195.

Scott HJ, McLeod RS, Blair J, O'Connor B, Cohen Z (1996) Ileal pouch–anal anastomosis: pregnancy, delivery and pouch function. Int J Colorectal Dis 11(2):84–87CrossRefPubMed

196.

Juhasz ES, Fozard B, Dozois RR, Ilstrup DM, Nelson H (1995) Ileal pouch–anal anastomosis function following childbirth. An extended evaluation. Dis Colon Rectum 38(2):159–165. https://doi.org/10.1007/bf02052444 CrossRefPubMed

197.

Counihan TC, Roberts PL, Schoetz DJ, Coller JA, Murray JJ, Veidenheimer MC (1994) Fertility and sexual and gynecologic function after ileal pouch–anal anastomosis. Dis Colon Rectum 37(11):1126–1129. https://doi.org/10.1007/bf02049815 CrossRefPubMed

198.

Hahnloser D, Pemberton JH, Wolff BG, Larson D, Harrington J, Farouk R, Dozois RR (2004) Pregnancy and delivery before and after ileal pouch–anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum 47(7):1127–1135. https://doi.org/10.1007/s10350-004-0569-0 CrossRefPubMed

199.

Sultan AH, Kamm MA, Hudson CN, Bartram CI (1993) Effect of pregnancy on anal sphincter morphology and function. Int J Colorectal Dis 8(4):206–209CrossRefPubMed

200.

Pinta TM, Kylänpää ML, Teramo KA, Luukkonen PS (2004) Sphincter rupture and anal incontinence after first vaginal delivery. Acta Obstet Gynecol Scand 83(10):917–922. https://doi.org/10.1111/j.0001-6349.2004.00346.x CrossRefPubMed

201.

Farouk R, Pemberton JH, Wolff BG, Dozois RR, Browning S, Larson D (2000) Functional outcomes after ileal pouch–anal anastomosis for chronic ulcerative colitis. Ann Surg 231(6):919–926. https://doi.org/10.1097/00000658-200006000-00017 CrossRefPubMedPubMedCentral

202.

Remzi FH, Gorgun E, Bast J, Schroeder T, Hammel J, Philipson E, Hull TL, Church JM, Fazio VW (2005) Vaginal delivery after ileal pouch–anal anastomosis: a word of caution. Dis Colon Rectum 48(9):1691–1699. https://doi.org/10.1007/s10350-005-0124-7 CrossRefPubMed

203.

Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, Leontiadis GI, Tse F, Mahadevan U, van der Woude CJ, Group IiPC, Gastroenterology CAo (2016) The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 150(3):734–757. https://doi.org/10.1053/j.gastro.2015.12.003 CrossRefPubMed

204.

Burke KE, Haviland MJ, Hacker MR, Shainker SA, Cheifetz AS (2017) Indications for mode of delivery in pregnant women with inflammatory bowel disease. Inflamm Bowel Dis 23(5):721–726. https://doi.org/10.1097/MIB.0000000000001113 CrossRefPubMed

205.

Scoglio D, Ahmed Ali U, Fichera A (2014) Surgical treatment of ulcerative colitis: ileorectal vs ileal pouch–anal anastomosis. World J Gastroenterol WJG 20(37):13211–13218. https://doi.org/10.3748/wjg.v20.i37.13211 CrossRefPubMed

206.

da Luz MA, Kiran RP, Lavery I (2010) Clinical outcomes of ileorectal anastomosis for ulcerative colitis. Br J Surg 97(1):65–69. https://doi.org/10.1002/bjs.6809 CrossRef

207.

Keating JP (2004) Sexual function after rectal excision. ANZ J Surg 74(4):248–259. https://doi.org/10.1111/j.1445-2197.2004.02954.x CrossRefPubMed

208.

Uzzan M, Cosnes J, Amiot A, Gornet JM, Seksik P, Cotte E, Tiret E, Panis Y, Treton X (2017) Long-term follow-up after ileorectal anastomosis for ulcerative colitis: a GETAID/GETAID chirurgie multicenter retrospective cohort of 343 patients. Ann Surg 266(6):1029–1034. https://doi.org/10.1097/SLA.0000000000002022 CrossRefPubMed

209.

Derikx LAAP, de Jong ME, Hoentjen F (2018) Short article: Recommendations on rectal surveillance for colorectal cancer after subtotal colectomy in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 30(8):843–846. https://doi.org/10.1097/MEG.0000000000001171 CrossRefPubMed

210.

Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR, Gastroenterology BSo, Ireland AoCfGBa (2010) Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59(5):666–689. https://doi.org/10.1136/gut.2009.179804 CrossRefPubMed

211.

Hultén L, Fasth S, Hallgren T, Oresland T (1992) The failing pelvic pouch conversion to continent ileostomy. Int J Colorectal Dis 7(3):119–121CrossRefPubMed

212.

Behrens DT, Paris M, Luttrell JN (1999) Conversion of failed ileal pouch–anal anastomosis to continent ileostomy. Dis Colon Rectum 42(4):490–495. https://doi.org/10.1007/bf02234174(discussion 495–496) CrossRefPubMed

213.

Aytac E, Ashburn J, Dietz DW (2014) Is there still a role for continent ileostomy in the surgical treatment of inflammatory bowel disease? Inflamm Bowel Dis 20(12):2519–2525. https://doi.org/10.1097/MIB.0000000000000160 CrossRefPubMed

214.

Ojerskog B, Hällström T, Kock NG, Myrvold HE (1988) Quality of life in ileostomy patients before and after conversion to the continent ileostomy. Int J Colorectal Dis 3(3):166–170CrossRefPubMed

215.

Nessar G, Fazio VW, Tekkis P, Connor J, Wu J, Bast J, Borkowski A, Delaney CP, Remzi FH (2006) Long-term outcome and quality of life after continent ileostomy. Dis Colon Rectum 49(3):336–344. https://doi.org/10.1007/s10350-005-0285-4 CrossRefPubMed

216.

Camilleri-Brennan J, Munro A, Steele RJ (2003) Does an ileoanal pouch offer a better quality of life than a permanent ileostomy for patients with ulcerative colitis? J Gastrointest Surg 7(6):814–819CrossRefPubMed

217.

Fasth S, Oresland T, Ahrén C, Hultén L (1985) Mucosal proctectomy and ileostomy as an alternative to conventional proctectomy. Dis Colon Rectum 28(1):31–34. https://doi.org/10.1007/bf02553903 CrossRefPubMed

218.

Nally DM, Kavanagh DO, Winter DC (2019) Close rectal dissection in benign diseases of the rectum: a review. Surgeon 17(2):119–126. https://doi.org/10.1016/j.surge.2018.06.002 CrossRefPubMed

219.

Zinicola R, Cracco N, Dalla Valle R, Bertolani M (2015) Preservation of the right mesocolon to avoid torsion of an end ileostomy. Colorectal Dis 17(3):265–266. https://doi.org/10.1111/codi.12908 CrossRefPubMed

220.

James SD, Hawkins AT, M'Koma AE (2018) Adenocarcinoma at the ileostomy site after a proctocolectomy for ulcerative colitis and/or familial adenomatous polyposis: an overview. Ostomy Wound Manage 64(6):30–40CrossRefPubMed

221.

Gooszen AW, Geelkerken RH, Hermans J, Lagaay MB, Gooszen HG (2000) Quality of life with a temporary stoma: ileostomy vs colostomy. Dis Colon Rectum 43(5):650–655. https://doi.org/10.1007/bf02235581 CrossRefPubMed

222.

Person B, Ifargan R, Lachter J, Duek SD, Kluger Y, Assalia A (2012) The impact of preoperative stoma site marking on the incidence of complications, quality of life, and patient's independence. Dis Colon Rectum 55(7):783–787. https://doi.org/10.1097/DCR.0b013e31825763f0 CrossRefPubMed

223.

Sier MF, Wisselink DD, Ubbink DT, Oostenbroek RJ, Veldink GJ, Lamme B, van Duijvendijk P, van Geloven AAW, Eijsbouts QAJ, Bemelman WA, group Its (2018) Randomized clinical trial of intracutaneously vs transcutaneously sutured ileostomy to prevent stoma-related complications (ISI trial). Br J Surg 105(6):637–644. https://doi.org/10.1002/bjs.10750 CrossRefPubMedPubMedCentral

224.

Lindberg J, Stenling R, Palmqvist R, Rutegård J (2006) Surgery for neoplastic changes in ulcerative colitis—can limited resection be justified? Outcome for patients who underwent limited surgery. Colorectal Dis 8(7):551–556. https://doi.org/10.1111/j.1463-1318.2006.00997.x CrossRefPubMed

225.

Fumery M, Dulai PS, Gupta S, Prokop LJ, Ramamoorthy S, Sandborn WJ, Singh S (2017) Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 15(5):665–674.e665. https://doi.org/10.1016/j.cgh.2016.11.025 CrossRefPubMed

226.

Khan N, Cole E, Shah Y, Paulson EC (2017) Segmental resection is a safe oncological alternative to total proctocolectomy in elderly patients with ulcerative colitis and malignancy. Colorectal Dis 19(12):1108–1116. https://doi.org/10.1111/codi.13721 CrossRefPubMed

227.

Krugliak Cleveland N, Ollech JE, Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Hurst R, Rubin DT (2019) Efficacy and follow-up of segmental or subtotal colectomy in patients with colitis-associated neoplasia. Clin Gastroenterol Hepatol 17(1):205–206. https://doi.org/10.1016/j.cgh.2018.04.061 CrossRefPubMed

228.

Myrelid P, Øresland T (2015) A reappraisal of the ileo-rectal anastomosis in ulcerative colitis. J Crohn's Colitis 9(6):433–438. https://doi.org/10.1093/ecco-jcc/jjv060 CrossRef

229.

Cohan JN, Bacchetti P, Varma MG, Finlayson E (2015) Impact of patient age on procedure type for ulcerative colitis: a national study. Dis Colon Rectum 58(8):769–774. https://doi.org/10.1097/DCR.0000000000000398 CrossRefPubMed

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2020

Do not snare post-THD pseudopolyps

What is the role of submucosal tattoos in device assisted enteroscopy?

Posterior pelvic tilt is a risk factor for rectal prolapse: a propensity score matching analysis

Cranial-first approach for safe laparoscopic surgery in right-sided colon cancer

Diagnostic accuracy of urinary intestinal fatty acid binding protein in detecting colorectal anastomotic leakage

Response to: What is the role of submucosal tattoos in device assisted enteroscopy?